Toddlers and preschoolers with cystic fibrosis can now have “life changing” medicine for a fraction of the price their families would usually pay.
A yearly course of Trikafta costs about $250,000 without any subsidies but children aged two to five will now be eligible for the medication through the Pharmaceutical Benefits Scheme from August 1.
#Cheaper #treatment #toddlers #condition
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
